Intrexon Corp. (XON) Issues Quarterly Earnings Results
Intrexon Corp. (NYSE:XON) announced its quarterly earnings results on Wednesday. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.21) by $0.03. Intrexon Corp. had a negative net margin of 96.65% and a negative return on equity of 19.00%. The business earned $48.99 million during the quarter, compared to analyst estimates of $51.70 million. During the same quarter last year, the company posted ($0.34) earnings per share. The company’s revenue was down 8.2% compared to the same quarter last year.
Intrexon Corp. (NYSE:XON) opened at 29.42 on Friday. The company’s market capitalization is $3.48 billion. Intrexon Corp. has a 52 week low of $18.52 and a 52 week high of $40.24. The company’s 50-day moving average is $27.22 and its 200 day moving average is $26.77.
Several equities analysts have issued reports on the stock. JMP Securities restated a “buy” rating on shares of Intrexon Corp. in a research report on Sunday, July 17th. Vetr cut shares of Intrexon Corp. from a “sell” rating to a “strong sell” rating and set a $22.26 price objective for the company. in a research report on Wednesday, July 27th. Zacks Investment Research upgraded shares of Intrexon Corp. from a “sell” rating to a “hold” rating in a research report on Monday, October 17th. Finally, Griffin Securities reiterated a “buy” rating and set a $55.00 price objective on shares of Intrexon Corp. in a research report on Tuesday, August 16th. Three research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. Intrexon Corp. presently has a consensus rating of “Buy” and an average target price of $41.71.
In related news, SVP Nir Nimrodi bought 4,000 shares of the company’s stock in a transaction on Monday, August 29th. The stock was acquired at an average cost of $26.12 per share, for a total transaction of $104,480.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 55.10% of the company’s stock.
Several large investors have recently made changes to their positions in XON. Aperio Group LLC acquired a new stake in shares of Intrexon Corp. during the first quarter worth $299,000. TIAA CREF Investment Management LLC raised its stake in shares of Intrexon Corp. by 2.3% in the first quarter. TIAA CREF Investment Management LLC now owns 141,930 shares of the company’s stock worth $4,810,000 after buying an additional 3,189 shares during the last quarter. Teachers Advisors Inc. raised its stake in shares of Intrexon Corp. by 8.9% in the first quarter. Teachers Advisors Inc. now owns 37,984 shares of the company’s stock worth $1,287,000 after buying an additional 3,104 shares during the last quarter. BlackRock Inc. raised its stake in shares of Intrexon Corp. by 321.0% in the first quarter. BlackRock Inc. now owns 5,780 shares of the company’s stock worth $195,000 after buying an additional 4,407 shares during the last quarter. Finally, BlackRock Group LTD raised its stake in shares of Intrexon Corp. by 9.1% in the first quarter. BlackRock Group LTD now owns 33,713 shares of the company’s stock worth $1,143,000 after buying an additional 2,816 shares during the last quarter. Hedge funds and other institutional investors own 84.12% of the company’s stock.
About Intrexon Corp.
Intrexon Corporation (Intrexon) forms collaborations to create biologically based products and processes using synthetic biology. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company’s synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale.
Receive News & Stock Ratings for Intrexon Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrexon Corp. and related stocks with our FREE daily email newsletter.